WSR 18-03-140
PROPOSED RULES
HORSE RACING COMMISSION
[Filed January 22, 2018, 11:37 a.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 17-17-067.
Title of Rule and Other Identifying Information: WAC 260-70-630 Threshold levels.
Hearing Location(s): On March 9, 2018, at 9:30 a.m, at the Auburn City Council Chambers, 25 West Main, Auburn, WA 98002.
Date of Intended Adoption: March 9, 2018.
Submit Written Comments to: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516, email doug.moore@whrc.state.wa.us, fax 360-549-6461 [360-459-6461], by March 2, 2018.
Assistance for Persons with Disabilities: Contact Patty Brown, phone 360-459-6462, fax 360-459-6461, email patty.brown@whrc.state.wa.us, by March 6, 2018.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: To amend threshold levels on approved therapeutic substances to recommended model rule standards.
Reasons Supporting Proposal: Based on scientific research the threshold levels will be amended to ARCI and RMTC recommended levels. This both protects the horse and ensures that is [it] does not compete with performance altering levels of therapeutic substances in its system.
Statutory Authority for Adoption: RCW 67.16.020.
Rule is not necessitated by federal law, federal or state court decision.
Name of Agency Personnel Responsible for Drafting, Implementation, and Enforcement: Douglas L. Moore, 6326 Martin Way, Suite 209, Olympia, WA 98516, 360-459-6462.
A school district fiscal impact statement is not required under RCW 28A.305.135.
A cost-benefit analysis is not required under RCW 34.05.328.
The proposed rule does not impose more-than-minor costs on businesses. Following is a summary of the agency's analysis showing how costs were calculated. Not business related.
January 22, 2018
Douglas L. Moore
Executive Secretary
AMENDATORY SECTION (Amending WSR 17-07-053, filed 3/10/17, effective 4/10/17)
WAC 260-70-630 Threshold levels.
(1) Permitted medications.
(a) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in urine:
Acepromazine - 10 ng/ml
Albuterol - 1 ng/ml
Bupivicaine - 5 ng/ml
Butorphanol - 300 ng/ml
Carboxydetomidine - 1 ng/ml
Clenbuterol - 140 pg/ml (in quarter horse and mixed breed races the presence of clenbuterol is prohibited)
Mepivacaine - 10 ng/ml
Promazine - 25 ng/ml
Pyrilamine - 25 ng/ml
(b) The following quantitative medications and/or metabolites are permissible in test samples up to the stated concentrations in serum or plasma:
Betamethasone - 10 pg/ml
Butorphanol - 2 ng/ml
Clenbuterol - ((25 pg/ml (in quarter horse and mixed breed races the presence of clenbuterol is prohibited))) Limit of detection
Cetirizine - 6 ng/ml
Cimetidine - 400 ng/ml
Dantrolene - 100 pg/ml
Detomidine - 1 ng/ml
Dexamethasone - ((.5 ng/ml)) 5 pg/ml
Diclofenac - 5 ng/ml
DMSO - 10 mcg/ml
Firocoxib - 20 ng/ml
Glycopryrrolate - 3 pg/ml
Guaifenesin - 12 ng/ml
Isoflupredone - 100 pg/ml
Lidocaine - 20 pg/ml
Methocarbamol - 1 ng/ml
Methylprednisolone - ((400)) 100 pg/ml
Omeprazole - 10 ng/ml
Prednisolone - 1 ng/ml
*Procaine penicillin - 25 ng/ml
Ranitidine - 40 ng/ml
Triamcinolone acetonide - 100 pg/ml
Xylazine - 200 pg/ml
*
Administration of procaine penicillin to those horses entered must be reported to the commission and may require surveillance up to six hours prior to post time.
(c) Hair samples in pre- or post-race testing for quarter horses and mixed breed races may not be found to contain clenbuterol, ractopamine, zilpaterol, or albuterol in any concentration.
(d) Where a permitted medication has thresholds in both urine and serum or plasma, as set forth in this section, it is not a defense to a violation that the permitted medication does not exceed both thresholds.
(2) Environmental substances.
(a) Certain substances can be considered "environmental" in that they are endogenous to the horse or that they can arise from plants traditionally grazed or harvested as equine feed or are present in equine feed because of contamination or exposure during the cultivation, processing, treatment, storage, or transportation phases. Certain drugs are recognized as substances of human use and could therefore be found in a horse. The following substances are permissible in test samples up to the stated concentrations:
Arsenic - 0.3 mcg/ml urine
Caffeine - 100 ng/ml serum or plasma
Cobalt - 50 ppb serum or plasma*
*
A level of 25 ppb in serum or plasma will result in the horse being placed on the official veterinarians list until such time as the level drops below the 25 ppb.
Benzoylecgonine - 50 ng/ml urine
Estranediol - 0.045 mcg/ml free + conjugated (5a-oestrane-3β,17a-diol), in the urine of male horses, other than geldings
Gamma Aminobutyric Acid (GABA) - 110 ng/ml in serum or plasma
Hydrocortisone - 1 mcg/ml urine
Methamphetamine - 10 ng/ml
Methoxytyramine - 4 mcg/ml, free + conjugated urine
Morphine Glucuronides - 50 ng/ml urine
Salicylate salicylic acid - 750 mcg/ml serum or plasma
Theobromine - 2 mcg/ml urine
Tramadol - 50 ng/ml urine
(b) If a preponderance of evidence presented shows that a positive test is the result of environmental substance or inadvertent exposure due to human drug use, that evidence should be considered as a mitigating factor in any disciplinary action taken against the trainer.
(3) Androgenic-anabolic steroids.
(a) The following androgenic-anabolic steroids are permissible in test samples up to the stated concentrations:
Boldenone (Equipoise) - 15 ng/ml urine in intact males - 1 ng/ml in urine for geldings, fillies or mares.
Nandrolone (Durabolin) - 1 ng/ml urine in geldings, fillies, and mares, and for nandrolone metabolite (5a-oestrane-3β,17a-diol) - 45 ng/ml urine in intact males.
Testosterone - 20 ng/ml urine in geldings. 55 ng/ml urine in fillies and mares. Samples from intact males will not be tested for the presence of testosterone.
(b) All other androgenic-anabolic steroids are prohibited in race horses.